Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
and, the list of professional psychics on this board grows ever the more steady.
"many folks should be tickled to add the name under $20.00...
Hey...I heard similar sentiments like that 5 months ago. Hope u dont start saying "under 19" again.
Dont take what he says seriously. Its for entertainment purposes only.
Why wouldn't it be below 20? The company has no approved drugs, nothing in the pipeline, unqualified staff, occupies a small basement rental unit, and has no potential for future growth......oh, wait a minute....
LoL!...Your proving my point for me. you pointed out her downfalls and yet she keeps being brought up by those on this board. You and others claim her inability to present ariads prospects correctly. Yet, theres her name again...Why?
Like i said, she must have some clout on this board.
she's been brought up on this board for a reason. does that mean she has some clout? LOL!
Hope your right, but she did lower her price target to 23. and from the looks of it, the stock price is now having a hard time staying above 20. hhhmmmm, how much does she know?
I think its way undervalued. Its hard to think that we are currently sub $20 a share. With an fda approved drug, a growing pipeline with unique and inspiring scientific technology (surely outside interest) and expansion of the co. on the horizon. Im not sure why the powers to be are thinking all that...for under $20?!
Really, quite disturbing
wish we were following the lawmakers over the cliff. Unfortunately, we have fallen a lot more than the overall market has, in the last two months.
Since beginning of oct. red days have dominated the landscape. How can a company be moving forward in reverse?
so lets say in 5 years from now, ariad has enjoyed a successful run. Are you saying that with the stand alone concept, the share price would be significantly higher at that point, rather than if we were owned?
when ariad raised enough capital to try and make it as a stand alone company, most on this board were pleased. It seems as if the tides have turned and there is now more favoritism towards a buyout. seems as if the pros of a buyout will double, maybe even triple the share price instantly. Can someone explain what the cons of a buyout (if any) would be, opposed to a stand alone, a few years down the road?
when ariad raised enough capital to try and make it as a stand alone company, most on this board were pleased. It seems as if the tides have turned and there is now more favoritism towards a buyout. seems as if the pros of a buyout will double, maybe even triple the share price instantly. Can someone explain what the cons of a buyout (if any) would be, opposed to a stand alone, a few years down the road?
True, god over money with this company. And although it does make one feel good about investing in a company that can save lives, realistically, we all came on board for the money. you would never put your "paper" in this high risk company back in the day, if there wasn't a possible payout waiting. True, god over money, but that should imply to any organization trying to find cures and not just the ones you have "paper" invested in.
most of the people on this board seem to be long with this stock. And although your outcome for the stock looks very rewarding, Its tough to think getting to those prices might mean an x amount of (more) years patiently waiting.
I for one would rather move on based on a certain numerical figure, instead of moving on due to time constraints.
so that means this stock could be undervalued until some time next year? that sounds terrible.
Lol! Only u vidpoc45. Read my opinioned reply to that posters question...remember, we're in it for the long haul! Lol!
For days after the fda drop, there hasn't been much going on other than people commenting on conspiracy theories, or speculating where the share price is going, or what the next catalyst will be and when. I guess those comments can only repeat themselves for so long, until people start loosing interest.
lol! looking forward to buying some
is ariad still waiting for an approval on ponatinib over in europe and asia? and if so, do you guys think that upon approval in those territories, the share price will follow a similar reaction, as it did last week?
No kidding right? As if anyone on this board can make a difference in share price, or in someones actions.
Realistically speaking, do you think that launch will take place after the 1st of the year? as was stated 2weeks after approval. Thus finally having 1st quarter revenues to speak of? And if so, should the incoming revenue eliminate any more talk about raising capital through share offerings?
i agree with you that the market has the price for ariad wrong (undervalued). Just look at what pcyc is worth in comparison (taking shares outstanding into account). But after this fda approval, what other news in the short term are you expecting?
"if you are talking about a non strategic buyout well that just aint going to happen. We aren't goign to get acquired by some private equity group. If you think we are, there is no use explaining to you why we are not."
I wasn't the one talking about any kind of buyout speculation.
Price retreating upon fda approval has brought out alot of buyout descussions on this board.
wouldn't a doctor want to investigate the data backing a newly fda approved drug in the market before prescribing it? And if thats the case, didn't pona have superior #s in comparison to some leading drugs that are already in the market? hence the accelerated approval. wouldnt that be enough for doctors to give considerations in recommending pona sooner, rather than latter?
volume doesn't seem to be a problem so far. Hopefully the price coming back wont be either.
Unlike yourself, I did not expect any sort of selloff from the get go once news of fda approval was made public. Maybe a pop in price, then some descend in the coming days/weeks. Although, with this company, it does Seem every time there is good news, its rapidly followed by a selloff. Never an upwards pop of 20% in a day! If this teaches us anything, at least we will now know what to expect upon ariads next drug approval.
However, with all the future possibilities you pointed out, I think the numbers you gave for share prices is still quite low. This is still an unofficial start for the company! We should continue to move upwards shortly. After all, provenge alone made that companies price gradually ascend into the 50s.
A curiosity question, to anyone with some knowledge behind splits. I recently saw a mention of Ariads growth in comparison to celgene. Upon looking at celg growth through the years, I noticed that they had three splits take place between $10 and $25, that was indicated on their yahoo charts. Is there significance for these splits? Does it help the companies maturation to have splits in that price range? Is Ariad in a position for a split in the near future with its own growth and realization of the company? Or is a split not even worth Ariads time? Thanks.
Nice find!...interesting read.
well, if approval happens before years end, you would be considered half right with your prediction.
Then again, you would also be half right if it happens after the new year. With those odds, you cant really lose! So, i'm also guessing a 50/50 chance for approval by years end as well...Just my thoughts.
from time to time, i have heard that we are at the current price per share because of the high marks ponatnib has received. and that the price reflects a pre-determined approval from the fda. If thats the case, does anyone think that the price should go higher upon an actual approval, as i think it should? Or at this point, does a separate catalyst need to take place, in order to breath in a new life of highs, from its current price?
well said
LOL!...$22 bounce? Why? Was that number supposed to be set in stone for a bounce?
Thought harvey was brilliant in making the rida deal with merck. However, it is unfortunate that another drug has missed its target in the fight against deadly diseases.
Fair enough
I assume the significance by starting the ph2 trials not only means that we have passed ph1, but that we could be much closer to market approval with ph2 success, and not have to wait for ph3.
Other than a possible early approval, do you suspect more good news to surface before then?
Kind of reminds me of when a team(s) in a sports draft puts doubt in a potential high pick, so he can possibly drop in the rankings...and possibly right to them.
Thats fine. and i commend you in your knowledge with investing. Still, its just an opinion that im entitled to, thats all. which i really haven't brought up to often. Definitely not constantly. Relax, lax.